Roche Supplies Xenical Weight Loss Drug to UK Diet Clinic

In July 2008 Roche Pharma in the UK was found to by the drug industry's self-regulatory body, the Prescription Medicines Code of Practice Authority, to have breached the code of practice by selling large amounts of the prescription-only weight-loss drug, Xenical, to the operator of a chain of private diet clinics. Roche was also found to have breached the code by agreeing to provide £55,000 to the clinic operator for the purchase of another clinic.

As a result of the adverse finding, Roche Pharma was suspended from membership of the Association of the British Pharmaceutical Industry (ABPI) for a minimum period of six months.

Other SourceWatch Resources

 * Drug industry
 * Pharmaceutical industry
 * Patient Groups
 * International Association for the Study of Obesity
 * International Obesity Task Force